From: Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil
Total | ICESP | HC-Barretos | |||||||
---|---|---|---|---|---|---|---|---|---|
HPV Type | ADC (n = 27)* | SCC (n = 143)* | p value | ADC (n = 12)* | SCC (n = 67)* | p value | ADC (n = 15)* | SCC (n = 76)* | p value |
11 | -- | 1 (0.7%) | >0.99 | -- | 1 (1.5%) | >0.99 | -- | -- | |
16 | 21 (65.5%) | 111 (76.7%) | 0.81 | 7 (58.3%) | 43 (64.2%) | 0.95 | 14 (93.3%) | 68 (89.5%) | >0.99 |
18 | 6 (20.7%) | 15 (7.5%) | 0.18 | 4 (33.3%) | 9 (13.4%) | 0.21 | 2 (13.3%) | 6 (7.9%) | 0.78 |
31 | 1 (3.4%) | 14 (9.6%) | 0.55 | 1 (8.3%) | 10 (14.9%) | 0.94 | -- | 4 (5.3%) | 0.96 |
33 | -- | 12 (8.2%) | 0.23 | -- | 6 (8.9%) | >0.99 | -- | 6 (7.9%) | 0.66 |
35 | 1 (3.4%) | 9 (6.8%) | >0.99 | 1 (8.3%) | 6 (9.0%) | >0.99 | -- | 4 (5.3%) | 0.96 |
39 | -- | 1 (0.7%) | >0.99 | -- | 1 (1.5%) | >0.99 | -- | -- | |
45 | 2 (17.2%) | 7 (3.4%) | 0.87 | 2 (16.7%) | 7 (10.4%) | 0.82 | -- | -- | |
52 | -- | 2 (2.0%) | >0.99 | -- | -- | -- | -- | 2 (2.6%) | >0.99 |
53 | -- | 1 (0.7%) | >0.99 | -- | 1 (1.5%) | >0.99 | -- | -- | |
56 | -- | 1 (1.4%) | >0.99 | -- | 1 (1.5%) | >0.99 | -- | -- | |
58 | -- | 3 (2.0%) | >0.99 | -- | 3 (4.5%) | >0.99 | -- | -- | |
59 | 2 (6.9%) | -- | 0.04 | 1 (8.3%) | -- | 0.30 | 1 (6.7%) | -- | 0.33 |
62 | -- | 2 (1.4%) | >0.99 | -- | 2 (3.0%) | >0.99 | -- | -- | |
72 | -- | 1 (0.7%) | >0.99 | -- | -- | -- | 1 (1.3%) | >0.99 | |
73 | -- | 3 (2.0%) | >0.99 | -- | 1 (1.5%) | >0.99 | -- | 2 (2.6%) | >0.99 |
84 | -- | 1 (0.7%) | >0.99 | -- | -- | -- | 1 (1.3%) | >0.99 |